INDIANAPOLIS (April 22, 2020) – BioCrossroads today released a new report which details the sources and amounts of capital supporting Indiana’s life sciences sector in 2019. An impressive $9.1 billion in capital was accessed by Indiana life sciences companies in 2019: $8.6 million Small Business Innovation Research (SBIR) grants were awarded to 21 companies; $177 million in venture capital was invested in 37 companies; $178.7 million was accessed through public markets by two companies; and, More than $8.7 billion was spent to acquire innovation, representing eight transactions. Indiana’s life sciences companies raised over $360 million, excluding the significant funding represented by mergers and acquisitions, in 2019.  These funds support innovation to discover and develop new therapies for diseases. “Having access to multiple capital investment vehicles fuels Indiana’s diverse and vibrant life sciences industry, which adds to the strength of the [...]

INDIANAPOLIS (March 27, 2020) –BioCrossroads today announced the winners of their DataX BioInnovation Challenge, a competition where innovators used data sets to identify and investigate a hypothesis aimed at improving two Indiana health issues – diabetes and opioid abuse. The Challenge was created to intersect life sciences and data research and encourage new ways of investigating traditional disease biology and public health outcomes’ questions. Founded on the premise that asking critical questions can leverage publicly available data sets, the Challenge sought to foster new solutions. Indiana Poison Center at IU Health won the diabetes challenge with a prize of $10,000. Their experiment is focused on the unintentional ingestion of Type II diabetes oral medications which can cause devastating hypoglycemia in children and adults. They will determine exposure rates of unintentional type II diabetes medications in both children and adults, as [...]

INDIANAPOLIS (March 24, 2020) -- Indiana’s life sciences industry keeps evolving, expanding, and making new discoveries. In 2019, companies made acquisitions and invested in their local operations; new organizations opened facilities in Indiana, bringing innovation and hundreds of new jobs to the landscape; and start-ups received venture funding to move their products forward. The result is a vibrant and growing Indiana life sciences sector. The sector showed notable growth in several areas as it continues to compete with coastal hubs in the size of its workforce, number of companies and productivity. Now 2,1571 companies and 56,5751 people strong (increases over previous years), the state continues to rank as one of the five most concentrated life sciences states in the United States. For the ninth straight year, Indiana is ranked as the second highest exporter of life sciences products in the U.S with more than $10.5 billion2 in exports, according to [...]